ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Hyperlipoproteinemia Type III

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Congenital, Hereditary, and Neonatal Diseases and Abnormalities ∟ Genetic Diseases, Inborn ∟ Metabolism, Inborn Errors ∟ Lipid Metabolism, Inborn Errors ∟ Hyperlipoproteinemia Type III 9 coordinate concepts ∟ Hyperlipoproteinemia Type I \| ∟ Hyperlipoproteinemia Type II \| ∟ Hyperlipoproteinemia Type IV \| ∟ Hyperlipoproteinemia Type V \| ∟ Hyperlipidemia, Familial Combined \| ∟ Hypolipoproteinemias \| ∟ Lipidoses \| ∟ Smith-Lemli-Opitz Syndrome \| ∟ Xanthomatosis, Cerebrotendinous Medical Subject Headings (MeSH) ∟ Nutritional and Metabolic Diseases ∟ Metabolic Diseases ∟ Lipid Metabolism Disorders ∟ Dyslipidemias ∟ Hyperlipidemias ∟ Hyperlipoproteinemias ∟ Hyperlipoproteinemia Type III 9 coordinate concepts ∟ Hyperlipoproteinemia Type I \| ∟ Hyperlipoproteinemia Type II \| ∟ Hyperlipoproteinemia Type IV \| ∟ Hyperlipoproteinemia Type V \| ∟ Hyperlipidemia, Familial Combined \| ∟ Hypolipoproteinemias \| ∟ Lipidoses \| ∟ Smith-Lemli-Opitz Syndrome \| ∟ Xanthomatosis, Cerebrotendinous Medical Subject Headings (MeSH) ∟ Nutritional and Metabolic Diseases ∟ Metabolic Diseases ∟ Metabolism, Inborn Errors ∟ Lipid Metabolism, Inborn Errors ∟ Hyperlipoproteinemia Type III 9 coordinate concepts ∟ Hyperlipoproteinemia Type I \| ∟ Hyperlipoproteinemia Type II \| ∟ Hyperlipoproteinemia Type IV \| ∟ Hyperlipoproteinemia Type V \| ∟ Hyperlipidemia, Familial Combined \| ∟ Hypolipoproteinemias \| ∟ Lipidoses \| ∟ Smith-Lemli-Opitz Syndrome \| ∟ Xanthomatosis, Cerebrotendinous X
Broader terms:	Medical Subject Headings (MeSH) ∟ Congenital, Hereditary, and Neonatal Diseases and Abnormalities ∟ Genetic Diseases, Inborn ∟ Metabolism, Inborn Errors ∟ Lipid Metabolism, Inborn Errors ∟ Hyperlipoproteinemia Type III Medical Subject Headings (MeSH) ∟ Nutritional and Metabolic Diseases ∟ Metabolic Diseases ∟ Lipid Metabolism Disorders ∟ Dyslipidemias ∟ Hyperlipidemias ∟ Hyperlipoproteinemias ∟ Hyperlipoproteinemia Type III Medical Subject Headings (MeSH) ∟ Nutritional and Metabolic Diseases ∟ Metabolic Diseases ∟ Metabolism, Inborn Errors ∟ Lipid Metabolism, Inborn Errors ∟ Hyperlipoproteinemia Type III Lipid Metabolism, Inborn Errors > Metabolism, Inborn Errors > Genetic Diseases, Inborn > Congenital, Hereditary, and Neonatal Diseases and Abnormalities > Medical Subject Headings (MeSH) Hyperlipoproteinemias > Hyperlipidemias > Dyslipidemias > Lipid Metabolism Disorders > Metabolic Diseases > Nutritional and Metabolic Diseases > Medical Subject Headings (MeSH) Lipid Metabolism, Inborn Errors > Metabolism, Inborn Errors > Metabolic Diseases > Nutritional and Metabolic Diseases > Medical Subject Headings (MeSH) X
History note:	Hyperlipidemia/familial & genetic (1966-1979)X
historyNote*:	80 X
publicMeSHNote*:	80 X
Scope note:	An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEIN E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides. X
activeMeSHYear*:	2007X
dateCreated*:	1979-04-23X
dateEstablished*:	1980-01-01X
dateRevised*:	2006-07-05X
recordAuthorizer*:	sjnX
recordMaintainer*:	lktX
recordOriginator*:	VDKX
Type:	Concept X
Coordinate terms:	Hyperlipoproteinemia Type I \| Hyperlipoproteinemia Type II \| Hyperlipoproteinemia Type IV \| Hyperlipoproteinemia Type V \| Hyperlipidemia, Familial Combined \| Hypolipoproteinemias \| Lipidoses \| Smith-Lemli-Opitz Syndrome \| Xanthomatosis, Cerebrotendinous X
URI:	X
Labels and equivalent concepts:	Tyypin III hyperlipoproteinemia (fi) Dysbeetalipoproteinemia (fi, replaced) Hyperlipoproteinemia, tyypin III (fi, replaced) Hyperlipoproteinemi typ III (sv) Hyperlipoproteinemia, Broad-beta (en, replaced) Familial Hypercholesterolemia with Hyperlipemia (en, replaced) Familial Dysbetalipoproteinemia (en, replaced) Dysbetalipoproteinemia (en, replaced) Dysbetalipoproteinemia, Familial (en, replaced) Broad Beta Disease (en, replaced) X
Share:	X